Sponsor or institution
Clinical trials and research at BioMarin Pharmaceutical
As of November 12, 2026, Find a Trial lists 10 clinical trials run by BioMarin Pharmaceutical that are recruiting, at sites in 14 countries (most in United States (10), Italy (6), Germany (5)). By phase: Phase 2 (2), Phase 4 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 14Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Immune Modulation During Palynziq Treatment in Adults | Phase 4 | Los Angeles, California and 11 other locations | Recruiting | Mar 17, 2026 |
| BMN 333 versus daily vosoritide for growth in children with achondroplasia | Phase 2/3 | Oakland, California and 27 other locations | Recruiting | Mar 2, 2026 |
| Daily vosoritide versus placebo for infants and toddlers with hypochondroplasia | Phase 2 | Phoenix, Arizona and 25 other locations | Recruiting | Aug 17, 2025 |
| Evaluating Vosoritide for Children with Short Stature | Phase 2 | California City, California and 46 other locations | Recruiting | Apr 24, 2024 |
| Assessing Growth in Children with Short Stature | — | Phoenix, Arizona and 37 other locations | Recruiting | Mar 13, 2024 |
| Long-term evaluation of immune response in PKU patients receiving Palynziq | — | Aurora, Colorado and 10 other locations | Recruiting | Mar 12, 2024 |
| Observational study of children with Hypochondroplasia | — | Phoenix, Arizona and 42 other locations | Recruiting | Jan 19, 2024 |
| Observational study of achondroplasia in the US | — | Oakland, California and 7 other locations | Recruiting | Dec 13, 2023 |
| Long-term safety assessment of pegvaliase in patients with PKU | — | Aurora, Colorado and 25 other locations | Recruiting | Apr 14, 2023 |
| Assessing the effects of Palynziq during pregnancy and breastfeeding | — | Wilmington, North Carolina and 3 other locations | Recruiting | Oct 14, 2022 |
All recruiting trials (10)
-
Immune Modulation During Palynziq Treatment in Adults
This study tests whether adding low-dose methotrexate can help people with PKU tolerate Palynziq better and achieve better blood levels of phenylalanine.
-
BMN 333 versus daily vosoritide for growth in children with achondroplasia
This trial tests whether weekly BMN 333 injections help children with achondroplasia grow as well as daily vosoritide.
-
Daily vosoritide versus placebo for infants and toddlers with hypochondroplasia
This trial will test whether daily vosoritide injections for 52 weeks help infants and toddlers under 36 months with genetically confirmed hypochondroplasia grow better and stay healthier.
-
Evaluating Vosoritide for Children with Short Stature
This study is testing a new treatment called vosoritide to see if it helps children with short stature grow better than the standard growth hormone treatment.
-
Assessing Growth in Children with Short Stature
This study is trying to gather information on how children with unexplained short stature grow to help improve future treatments for them.
-
Long-term evaluation of immune response in PKU patients receiving Palynziq
This study is testing how well Palynziq works over 10 years for people with PKU by looking at their immune responses and overall health.
-
Observational study of children with Hypochondroplasia
This study is tracking the growth and development of children with Hypochondroplasia to see how the condition affects them as they grow up.
-
Observational study of achondroplasia in the US
This study looks at children in the U.S. with achondroplasia to see how they are doing with and without the treatment VOXZOGO™ over at least five years.
-
Long-term safety assessment of pegvaliase in patients with PKU
This study is testing the long-term safety of pegvaliase in people with PKU to see how well it works and if there are any side effects over time.
-
Assessing the effects of Palynziq during pregnancy and breastfeeding
This study looks at how the medication Palynziq affects women with PKU and their babies during pregnancy and breastfeeding.
Quick answers
How many clinical trials run by BioMarin Pharmaceutical are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in United States (10 trials), Italy (6 trials), Germany (5 trials), Australia (4 trials), France (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 4: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.